| Map | KEGG Pathway | Nmap | Norg | Nid | Norgid |
|---|
| hsa00010 | Glycolysis / Gluconeogenesis |
perl |
/home/masstrix3/exec/31 |
26 |
0 |
| hsa00020 | Citrate cycle (TCA cycle) |
perl |
/home/masstrix3/exec/20 |
17 |
0 |
| hsa00030 | Pentose phosphate pathway |
perl |
/home/masstrix3/exec/32 |
21 |
0 |
| hsa00040 | Pentose and glucuronate interconversions |
perl |
/home/masstrix3/exec/55 |
16 |
1 |
| hsa00051 | Fructose and mannose metabolism |
perl |
/home/masstrix3/exec/48 |
19 |
0 |
| hsa00052 | Galactose metabolism |
perl |
/home/masstrix3/exec/41 |
17 |
1 |
| hsa00053 | Ascorbate and aldarate metabolism |
perl |
/home/masstrix3/exec/47 |
9 |
0 |
| hsa00061 | Fatty acid biosynthesis |
perl |
/home/masstrix3/exec/49 |
20 |
5 |
| hsa00062 | Fatty acid elongation |
perl |
/home/masstrix3/exec/36 |
19 |
1 |
| hsa00071 | Fatty acid metabolism |
perl |
/home/masstrix3/exec/50 |
27 |
2 |
| hsa00072 | Synthesis and degradation of ketone bodies |
perl |
/home/masstrix3/exec/6 |
5 |
0 |
| hsa00100 | Steroid biosynthesis |
perl |
/home/masstrix3/exec/51 |
29 |
1 |
| hsa00120 | Primary bile acid biosynthesis |
perl |
/home/masstrix3/exec/47 |
33 |
0 |
| hsa00130 | Ubiquinone and other terpenoid-quinone biosynthesis |
perl |
/home/masstrix3/exec/76 |
11 |
2 |
| hsa00140 | Steroid hormone biosynthesis |
perl |
/home/masstrix3/exec/99 |
33 |
11 |
| hsa00190 | Oxidative phosphorylation |
perl |
/home/masstrix3/exec/16 |
13 |
0 |
| hsa00230 | Purine metabolism |
perl |
/home/masstrix3/exec/92 |
61 |
12 |
| hsa00232 | Caffeine metabolism |
perl |
/home/masstrix3/exec/21 |
3 |
0 |
| hsa00240 | Pyrimidine metabolism |
perl |
/home/masstrix3/exec/59 |
40 |
6 |
| hsa00250 | Alanine, aspartate and glutamate metabolism |
perl |
/home/masstrix3/exec/24 |
24 |
3 |
| hsa00260 | Glycine, serine and threonine metabolism |
perl |
/home/masstrix3/exec/49 |
28 |
8 |
| hsa00270 | Cysteine and methionine metabolism |
perl |
/home/masstrix3/exec/56 |
29 |
8 |
| hsa00280 | Valine, leucine and isoleucine degradation |
perl |
/home/masstrix3/exec/41 |
35 |
4 |
| hsa00290 | Valine, leucine and isoleucine biosynthesis |
perl |
/home/masstrix3/exec/24 |
8 |
4 |
| hsa00300 | Lysine biosynthesis |
perl |
/home/masstrix3/exec/32 |
5 |
3 |
| hsa00310 | Lysine degradation |
perl |
/home/masstrix3/exec/47 |
24 |
10 |
| hsa00330 | Arginine and proline metabolism |
perl |
/home/masstrix3/exec/90 |
41 |
19 |
| hsa00340 | Histidine metabolism |
perl |
/home/masstrix3/exec/44 |
14 |
6 |
| hsa00350 | Tyrosine metabolism |
perl |
/home/masstrix3/exec/76 |
23 |
3 |
| hsa00360 | Phenylalanine metabolism |
perl |
/home/masstrix3/exec/63 |
8 |
10 |
| hsa00380 | Tryptophan metabolism |
perl |
/home/masstrix3/exec/80 |
32 |
4 |
| hsa00400 | Phenylalanine, tyrosine and tryptophan biosynthesis |
perl |
/home/masstrix3/exec/27 |
5 |
4 |
| hsa00410 | beta-Alanine metabolism |
perl |
/home/masstrix3/exec/31 |
18 |
5 |
| hsa00430 | Taurine and hypotaurine metabolism |
perl |
/home/masstrix3/exec/22 |
8 |
3 |
| hsa00450 | Selenocompound metabolism |
perl |
/home/masstrix3/exec/27 |
16 |
1 |
| hsa00460 | Cyanoamino acid metabolism |
perl |
/home/masstrix3/exec/43 |
5 |
3 |
| hsa00471 | D-Glutamine and D-glutamate metabolism |
perl |
/home/masstrix3/exec/12 |
5 |
6 |
| hsa00472 | D-Arginine and D-ornithine metabolism |
perl |
/home/masstrix3/exec/10 |
0 |
5 |
| hsa00480 | Glutathione metabolism |
perl |
/home/masstrix3/exec/38 |
22 |
9 |
| hsa00500 | Starch and sucrose metabolism |
perl |
/home/masstrix3/exec/50 |
26 |
1 |
| hsa00510 | N-Glycan biosynthesis |
perl |
/home/masstrix3/exec/13 |
11 |
0 |
| hsa00511 | Other glycan degradation |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa00512 | Mucin type O-Glycan biosynthesis |
perl |
/home/masstrix3/exec/8 |
6 |
0 |
| hsa00514 | Other types of O-glycan biosynthesis |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa00520 | Amino sugar and nucleotide sugar metabolism |
perl |
/home/masstrix3/exec/87 |
37 |
7 |
| hsa00524 | Butirosin and neomycin biosynthesis |
perl |
/home/masstrix3/exec/29 |
2 |
1 |
| hsa00531 | Glycosaminoglycan degradation |
perl |
/home/masstrix3/exec/4 |
1 |
0 |
| hsa00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate |
perl |
/home/masstrix3/exec/5 |
5 |
0 |
| hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa00534 | Glycosaminoglycan biosynthesis - heparan sulfate |
perl |
/home/masstrix3/exec/5 |
4 |
0 |
| hsa00561 | Glycerolipid metabolism |
perl |
/home/masstrix3/exec/33 |
14 |
0 |
| hsa00562 | Inositol phosphate metabolism |
perl |
/home/masstrix3/exec/39 |
32 |
0 |
| hsa00563 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis |
perl |
/home/masstrix3/exec/6 |
5 |
1 |
| hsa00564 | Glycerophospholipid metabolism |
perl |
/home/masstrix3/exec/46 |
29 |
2 |
| hsa00565 | Ether lipid metabolism |
perl |
/home/masstrix3/exec/23 |
16 |
1 |
| hsa00590 | Arachidonic acid metabolism |
perl |
/home/masstrix3/exec/75 |
25 |
31 |
| hsa00591 | Linoleic acid metabolism |
perl |
/home/masstrix3/exec/26 |
4 |
1 |
| hsa00592 | alpha-Linolenic acid metabolism |
perl |
/home/masstrix3/exec/40 |
3 |
1 |
| hsa00600 | Sphingolipid metabolism |
perl |
/home/masstrix3/exec/25 |
21 |
6 |
| hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series |
perl |
/home/masstrix3/exec/9 |
5 |
0 |
| hsa00603 | Glycosphingolipid biosynthesis - globo series |
perl |
/home/masstrix3/exec/4 |
4 |
0 |
| hsa00604 | Glycosphingolipid biosynthesis - ganglio series |
perl |
/home/masstrix3/exec/14 |
13 |
0 |
| hsa00620 | Pyruvate metabolism |
perl |
/home/masstrix3/exec/32 |
18 |
1 |
| hsa00630 | Glyoxylate and dicarboxylate metabolism |
perl |
/home/masstrix3/exec/50 |
21 |
0 |
| hsa00640 | Propanoate metabolism |
perl |
/home/masstrix3/exec/36 |
18 |
1 |
| hsa00650 | Butanoate metabolism |
perl |
/home/masstrix3/exec/40 |
17 |
1 |
| hsa00670 | One carbon pool by folate |
perl |
/home/masstrix3/exec/9 |
9 |
0 |
| hsa00730 | Thiamine metabolism |
perl |
/home/masstrix3/exec/26 |
7 |
2 |
| hsa00740 | Riboflavin metabolism |
perl |
/home/masstrix3/exec/23 |
6 |
1 |
| hsa00750 | Vitamin B6 metabolism |
perl |
/home/masstrix3/exec/32 |
10 |
6 |
| hsa00760 | Nicotinate and nicotinamide metabolism |
perl |
/home/masstrix3/exec/47 |
11 |
4 |
| hsa00770 | Pantothenate and CoA biosynthesis |
perl |
/home/masstrix3/exec/28 |
18 |
2 |
| hsa00780 | Biotin metabolism |
perl |
/home/masstrix3/exec/11 |
5 |
3 |
| hsa00785 | Lipoic acid metabolism |
perl |
/home/masstrix3/exec/6 |
4 |
1 |
| hsa00790 | Folate biosynthesis |
perl |
/home/masstrix3/exec/29 |
15 |
2 |
| hsa00830 | Retinol metabolism |
perl |
/home/masstrix3/exec/24 |
11 |
7 |
| hsa00860 | Porphyrin and chlorophyll metabolism |
perl |
/home/masstrix3/exec/124 |
27 |
3 |
| hsa00900 | Terpenoid backbone biosynthesis |
perl |
/home/masstrix3/exec/32 |
13 |
2 |
| hsa00910 | Nitrogen metabolism |
perl |
/home/masstrix3/exec/26 |
11 |
2 |
| hsa00920 | Sulfur metabolism |
perl |
/home/masstrix3/exec/18 |
5 |
2 |
| hsa00970 | Aminoacyl-tRNA biosynthesis |
perl |
/home/masstrix3/exec/53 |
46 |
14 |
| hsa00980 | Metabolism of xenobiotics by cytochrome P450 |
perl |
/home/masstrix3/exec/121 |
12 |
3 |
| hsa00982 | Drug metabolism - cytochrome P450 |
perl |
/home/masstrix3/exec/87 |
0 |
3 |
| hsa00983 | Drug metabolism - other enzymes |
perl |
/home/masstrix3/exec/39 |
20 |
1 |
| hsa01040 | Biosynthesis of unsaturated fatty acids |
perl |
/home/masstrix3/exec/54 |
8 |
7 |
| N/A | Metabolic pathways |
perl |
/home/masstrix3/exec/1528 |
675 |
122 |
| hsa02010 | ABC transporters |
perl |
/home/masstrix3/exec/91 |
0 |
17 |
| hsa03008 | Ribosome biogenesis in eukaryotes |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa03010 | Ribosome |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa03013 | RNA transport |
perl |
/home/masstrix3/exec/3 |
0 |
1 |
| hsa03015 | mRNA surveillance pathway |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa03018 | RNA degradation |
perl |
/home/masstrix3/exec/1 |
0 |
0 |
| hsa03020 | RNA polymerase |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa03022 | Basal transcription factors |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa03030 | DNA replication |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa03040 | Spliceosome |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa03050 | Proteasome |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa03060 | Protein export |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa03320 | PPAR signaling pathway |
perl |
/home/masstrix3/exec/5 |
0 |
1 |
| hsa03410 | Base excision repair |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa03420 | Nucleotide excision repair |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa03430 | Mismatch repair |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa03440 | Homologous recombination |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa03450 | Non-homologous end-joining |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa03460 | Fanconi anemia pathway |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04010 | MAPK signaling pathway |
perl |
/home/masstrix3/exec/5 |
0 |
0 |
| hsa04012 | ErbB signaling pathway |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa04020 | Calcium signaling pathway |
perl |
/home/masstrix3/exec/10 |
0 |
0 |
| hsa04060 | Cytokine-cytokine receptor interaction |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04062 | Chemokine signaling pathway |
perl |
/home/masstrix3/exec/5 |
0 |
0 |
| hsa04070 | Phosphatidylinositol signaling system |
perl |
/home/masstrix3/exec/27 |
0 |
0 |
| hsa04080 | Neuroactive ligand-receptor interaction |
perl |
/home/masstrix3/exec/128 |
0 |
8 |
| hsa04110 | Cell cycle |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04114 | Oocyte meiosis |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa04115 | p53 signaling pathway |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04120 | Ubiquitin mediated proteolysis |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04122 | Sulfur relay system |
perl |
/home/masstrix3/exec/10 |
0 |
2 |
| hsa04130 | SNARE interactions in vesicular transport |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04140 | Regulation of autophagy |
perl |
/home/masstrix3/exec/5 |
0 |
0 |
| hsa04141 | Protein processing in endoplasmic reticulum |
perl |
/home/masstrix3/exec/1 |
0 |
0 |
| hsa04142 | Lysosome |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa04144 | Endocytosis |
perl |
/home/masstrix3/exec/7 |
0 |
0 |
| hsa04145 | Phagosome |
perl |
/home/masstrix3/exec/5 |
0 |
0 |
| hsa04146 | Peroxisome |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04150 | mTOR signaling pathway |
perl |
/home/masstrix3/exec/9 |
0 |
0 |
| hsa04210 | Apoptosis |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04260 | Cardiac muscle contraction |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa04270 | Vascular smooth muscle contraction |
perl |
/home/masstrix3/exec/25 |
0 |
9 |
| hsa04310 | Wnt signaling pathway |
perl |
/home/masstrix3/exec/1 |
0 |
0 |
| hsa04320 | Dorso-ventral axis formation |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04330 | Notch signaling pathway |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04340 | Hedgehog signaling pathway |
perl |
/home/masstrix3/exec/1 |
0 |
0 |
| hsa04350 | TGF-beta signaling pathway |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04360 | Axon guidance |
perl |
/home/masstrix3/exec/1 |
0 |
0 |
| hsa04370 | VEGF signaling pathway |
perl |
/home/masstrix3/exec/6 |
0 |
1 |
| hsa04380 | Osteoclast differentiation |
perl |
/home/masstrix3/exec/3 |
0 |
0 |
| hsa04510 | Focal adhesion |
perl |
/home/masstrix3/exec/2 |
0 |
0 |
| hsa04512 | ECM-receptor interaction |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04514 | Cell adhesion molecules (CAMs) |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04520 | Adherens junction |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04530 | Tight junction |
perl |
/home/masstrix3/exec/1 |
0 |
0 |
| hsa04540 | Gap junction |
perl |
/home/masstrix3/exec/11 |
0 |
2 |
| hsa04610 | Complement and coagulation cascades |
perl |
/home/masstrix3/exec/2 |
0 |
0 |
| hsa04612 | Antigen processing and presentation |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04614 | Renin-angiotensin system |
perl |
/home/masstrix3/exec/7 |
0 |
0 |
| hsa04620 | Toll-like receptor signaling pathway |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04621 | NOD-like receptor signaling pathway |
perl |
/home/masstrix3/exec/1 |
0 |
0 |
| hsa04622 | RIG-I-like receptor signaling pathway |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04623 | Cytosolic DNA-sensing pathway |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04630 | Jak-STAT signaling pathway |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04640 | Hematopoietic cell lineage |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04650 | Natural killer cell mediated cytotoxicity |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa04660 | T cell receptor signaling pathway |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa04662 | B cell receptor signaling pathway |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa04664 | Fc epsilon RI signaling pathway |
perl |
/home/masstrix3/exec/11 |
0 |
2 |
| hsa04666 | Fc gamma R-mediated phagocytosis |
perl |
/home/masstrix3/exec/8 |
0 |
1 |
| hsa04670 | Leukocyte transendothelial migration |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa04672 | Intestinal immune network for IgA production |
perl |
/home/masstrix3/exec/2 |
0 |
0 |
| hsa04710 | Circadian rhythm - mammal |
perl |
/home/masstrix3/exec/2 |
0 |
0 |
| hsa04720 | Long-term potentiation |
perl |
/home/masstrix3/exec/7 |
0 |
1 |
| hsa04721 | Synaptic vesicle cycle |
perl |
/home/masstrix3/exec/12 |
0 |
1 |
| hsa04722 | Neurotrophin signaling pathway |
perl |
/home/masstrix3/exec/5 |
0 |
0 |
| hsa04724 | Glutamatergic synapse |
perl |
/home/masstrix3/exec/8 |
0 |
2 |
| hsa04725 | Cholinergic synapse |
perl |
/home/masstrix3/exec/12 |
0 |
0 |
| hsa04727 | GABAergic synapse |
perl |
/home/masstrix3/exec/9 |
0 |
2 |
| hsa04728 | Dopaminergic synapse |
perl |
/home/masstrix3/exec/12 |
0 |
1 |
| hsa04730 | Long-term depression |
perl |
/home/masstrix3/exec/9 |
0 |
3 |
| hsa04740 | Olfactory transduction |
perl |
/home/masstrix3/exec/5 |
0 |
1 |
| hsa04742 | Taste transduction |
perl |
/home/masstrix3/exec/13 |
0 |
2 |
| hsa04744 | Phototransduction |
perl |
/home/masstrix3/exec/8 |
0 |
3 |
| hsa04810 | Regulation of actin cytoskeleton |
perl |
/home/masstrix3/exec/6 |
0 |
0 |
| hsa04910 | Insulin signaling pathway |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa04912 | GnRH signaling pathway |
perl |
/home/masstrix3/exec/6 |
0 |
1 |
| hsa04914 | Progesterone-mediated oocyte maturation |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa04916 | Melanogenesis |
perl |
/home/masstrix3/exec/6 |
0 |
1 |
| hsa04920 | Adipocytokine signaling pathway |
perl |
/home/masstrix3/exec/7 |
0 |
0 |
| hsa04930 | Type II diabetes mellitus |
perl |
/home/masstrix3/exec/6 |
0 |
0 |
| hsa04940 | Type I diabetes mellitus |
perl |
/home/masstrix3/exec/3 |
0 |
0 |
| hsa04950 | Maturity onset diabetes of the young |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa04960 | Aldosterone-regulated sodium reabsorption |
perl |
/home/masstrix3/exec/8 |
0 |
0 |
| hsa04961 | Endocrine and other factor-regulated calcium reabsorption |
perl |
/home/masstrix3/exec/9 |
0 |
0 |
| hsa04962 | Vasopressin-regulated water reabsorption |
perl |
/home/masstrix3/exec/2 |
0 |
0 |
| hsa04964 | Proximal tubule bicarbonate reclamation |
perl |
/home/masstrix3/exec/17 |
0 |
2 |
| hsa04966 | Collecting duct acid secretion |
perl |
/home/masstrix3/exec/8 |
0 |
0 |
| hsa04970 | Salivary secretion |
perl |
/home/masstrix3/exec/17 |
0 |
1 |
| hsa04971 | Gastric acid secretion |
perl |
/home/masstrix3/exec/14 |
0 |
0 |
| hsa04972 | Pancreatic secretion |
perl |
/home/masstrix3/exec/17 |
0 |
0 |
| hsa04973 | Carbohydrate digestion and absorption |
perl |
/home/masstrix3/exec/27 |
0 |
0 |
| hsa04974 | Protein digestion and absorption |
perl |
/home/masstrix3/exec/47 |
0 |
13 |
| hsa04975 | Fat digestion and absorption |
perl |
/home/masstrix3/exec/12 |
0 |
0 |
| hsa04976 | Bile secretion |
perl |
/home/masstrix3/exec/147 |
0 |
12 |
| hsa04977 | Vitamin digestion and absorption |
perl |
/home/masstrix3/exec/38 |
0 |
5 |
| hsa04978 | Mineral absorption |
perl |
/home/masstrix3/exec/29 |
0 |
8 |
| hsa05010 | Alzheimer's disease |
perl |
/home/masstrix3/exec/7 |
0 |
0 |
| hsa05012 | Parkinson's disease |
perl |
/home/masstrix3/exec/13 |
0 |
2 |
| hsa05014 | Amyotrophic lateral sclerosis (ALS) |
perl |
/home/masstrix3/exec/10 |
0 |
2 |
| hsa05016 | Huntington's disease |
perl |
/home/masstrix3/exec/3 |
0 |
1 |
| hsa05020 | Prion diseases |
perl |
/home/masstrix3/exec/3 |
0 |
0 |
| hsa05100 | Bacterial invasion of epithelial cells |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa05110 | Vibrio cholerae infection |
perl |
/home/masstrix3/exec/9 |
0 |
0 |
| hsa05120 | Epithelial cell signaling in Helicobacter pylori infection |
perl |
/home/masstrix3/exec/5 |
0 |
0 |
| hsa05130 | Pathogenic Escherichia coli infection |
perl |
/home/masstrix3/exec/1 |
0 |
0 |
| hsa05131 | Shigellosis |
perl |
/home/masstrix3/exec/2 |
0 |
0 |
| hsa05132 | Salmonella infection |
perl |
/home/masstrix3/exec/4 |
0 |
1 |
| hsa05133 | Pertussis |
perl |
/home/masstrix3/exec/10 |
0 |
0 |
| hsa05134 | Legionellosis |
perl |
/home/masstrix3/exec/2 |
0 |
0 |
| hsa05140 | Leishmaniasis |
perl |
/home/masstrix3/exec/6 |
0 |
2 |
| hsa05142 | Chagas disease (American trypanosomiasis) |
perl |
/home/masstrix3/exec/7 |
0 |
1 |
| hsa05143 | African trypanosomiasis |
perl |
/home/masstrix3/exec/10 |
0 |
3 |
| hsa05144 | Malaria |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa05145 | Toxoplasmosis |
perl |
/home/masstrix3/exec/3 |
0 |
1 |
| hsa05146 | Amoebiasis |
perl |
/home/masstrix3/exec/13 |
0 |
3 |
| hsa05150 | Staphylococcus aureus infection |
perl |
/home/masstrix3/exec/12 |
0 |
0 |
| hsa05152 | Tuberculosis |
perl |
/home/masstrix3/exec/9 |
0 |
0 |
| hsa05160 | Hepatitis C |
perl |
/home/masstrix3/exec/8 |
0 |
0 |
| hsa05162 | Measles |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa05164 | Influenza A |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa05166 | HTLV-I infection |
perl |
/home/masstrix3/exec/9 |
0 |
0 |
| hsa05168 | Herpes simplex infection |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa05200 | Pathways in cancer |
perl |
/home/masstrix3/exec/20 |
0 |
3 |
| hsa05210 | Colorectal cancer |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa05211 | Renal cell carcinoma |
perl |
/home/masstrix3/exec/3 |
0 |
0 |
| hsa05212 | Pancreatic cancer |
perl |
/home/masstrix3/exec/2 |
0 |
0 |
| hsa05213 | Endometrial cancer |
perl |
/home/masstrix3/exec/1 |
0 |
0 |
| hsa05214 | Glioma |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa05215 | Prostate cancer |
perl |
/home/masstrix3/exec/11 |
0 |
3 |
| hsa05216 | Thyroid cancer |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa05217 | Basal cell carcinoma |
perl |
/home/masstrix3/exec/1 |
0 |
0 |
| hsa05218 | Melanoma |
perl |
/home/masstrix3/exec/1 |
0 |
0 |
| hsa05219 | Bladder cancer |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa05220 | Chronic myeloid leukemia |
perl |
/home/masstrix3/exec/1 |
0 |
0 |
| hsa05221 | Acute myeloid leukemia |
perl |
/home/masstrix3/exec/1 |
0 |
0 |
| hsa05222 | Small cell lung cancer |
perl |
/home/masstrix3/exec/3 |
0 |
0 |
| hsa05223 | Non-small cell lung cancer |
perl |
/home/masstrix3/exec/6 |
0 |
0 |
| hsa05310 | Asthma |
perl |
/home/masstrix3/exec/5 |
0 |
1 |
| hsa05320 | Autoimmune thyroid disease |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa05322 | Systemic lupus erythematosus |
perl |
/home/masstrix3/exec/3 |
0 |
0 |
| hsa05323 | Rheumatoid arthritis |
perl |
/home/masstrix3/exec/4 |
0 |
1 |
| hsa05330 | Allograft rejection |
perl |
/home/masstrix3/exec/1 |
0 |
0 |
| hsa05332 | Graft-versus-host disease |
perl |
/home/masstrix3/exec/2 |
0 |
0 |
| hsa05340 | Primary immunodeficiency |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
| hsa05410 | Hypertrophic cardiomyopathy (HCM) |
perl |
/home/masstrix3/exec/5 |
0 |
0 |
| hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) |
perl |
/home/masstrix3/exec/2 |
0 |
0 |
| hsa05414 | Dilated cardiomyopathy |
perl |
/home/masstrix3/exec/4 |
0 |
0 |
| hsa05416 | Viral myocarditis |
perl |
/home/masstrix3/exec/0 |
0 |
0 |
